Otto Christoph, Kaemmerer Ulrike, Illert Bertram, Muehling Bettina, Pfetzer Nadja, Wittig Rainer, Voelker Hans Ullrich, Thiede Arnulf, Coy Johannes F
Experimental Transplantation Immunology, Department of Surgery, University of Würzburg Hospital, Oberdürrbacher Str, 6, D-97080 Würzburg, Germany.
BMC Cancer. 2008 Apr 30;8:122. doi: 10.1186/1471-2407-8-122.
BACKGROUND: Among the most prominent metabolic alterations in cancer cells are the increase in glucose consumption and the conversion of glucose to lactic acid via the reduction of pyruvate even in the presence of oxygen. This phenomenon, known as aerobic glycolysis or the Warburg effect, may provide a rationale for therapeutic strategies that inhibit tumour growth by administration of a ketogenic diet with average protein but low in carbohydrates and high in fat enriched with omega-3 fatty acids and medium-chain triglycerides (MCT). METHODS: Twenty-four female NMRI nude mice were injected subcutaneously with tumour cells of the gastric adenocarcinoma cell line 23132/87. The animals were then randomly split into two feeding groups and fed either a ketogenic diet (KD group; n = 12) or a standard diet (SD group; n = 12) ad libitum. Experiments were ended upon attainment of the target tumor volume of 600 mm3 to 700 mm3. The two diets were compared based on tumour growth and survival time (interval between tumour cell injection and attainment of target tumour volume). RESULTS: The ketogenic diet was well accepted by the KD mice. The tumour growth in the KD group was significantly delayed compared to that in the SD group. Tumours in the KD group reached the target tumour volume at 34.2 +/- 8.5 days versus only 23.3 +/- 3.9 days in the SD group. After day 20, tumours in the KD group grew faster although the differences in mean tumour growth continued significantly. Importantly, they revealed significantly larger necrotic areas than tumours of the SD group and the areas with vital tumour cells appear to have had fewer vessels than tumours of the SD group. Viable tumour cells in the border zone surrounding the necrotic areas of tumours of both groups exhibited a glycolytic phenotype with expression of glucose transporter-1 and transketolase-like 1 enzyme. CONCLUSION: Application of an unrestricted ketogenic diet enriched with omega-3 fatty acids and MCT delayed tumour growth in a mouse xenograft model. Further studies are needed to address the impact of this diet on other tumour-relevant functions such as invasive growth and metastasis.
背景:癌细胞中最显著的代谢改变之一是即使在有氧条件下,葡萄糖消耗增加以及通过丙酮酸还原将葡萄糖转化为乳酸。这种现象,即所谓的有氧糖酵解或瓦伯格效应,可能为通过给予平均蛋白质含量但碳水化合物含量低且富含ω-3脂肪酸和中链甘油三酯(MCT)的高脂肪生酮饮食来抑制肿瘤生长的治疗策略提供理论依据。 方法:将24只雌性NMRI裸鼠皮下注射胃腺癌细胞系23132/87的肿瘤细胞。然后将动物随机分为两个喂养组,随意给予生酮饮食(KD组;n = 12)或标准饮食(SD组;n = 12)。当达到600立方毫米至700立方毫米的目标肿瘤体积时实验结束。根据肿瘤生长和生存时间(肿瘤细胞注射与达到目标肿瘤体积之间的间隔)对两种饮食进行比较。 结果:KD小鼠很好地接受了生酮饮食。与SD组相比,KD组的肿瘤生长明显延迟。KD组的肿瘤在34.2±8.5天达到目标肿瘤体积,而SD组仅在23.3±3.9天达到。在第20天后,KD组的肿瘤生长更快,尽管平均肿瘤生长的差异仍然显著。重要的是,它们显示出比SD组的肿瘤明显更大的坏死区域,并且有活力的肿瘤细胞区域的血管似乎比SD组的肿瘤少。两组肿瘤坏死区域周围边界区的存活肿瘤细胞均表现出具有葡萄糖转运蛋白-1和转酮醇酶样1酶表达的糖酵解表型。 结论:在小鼠异种移植模型中,应用富含ω-3脂肪酸和MCT的无限制生酮饮食可延迟肿瘤生长。需要进一步研究来探讨这种饮食对其他肿瘤相关功能(如侵袭性生长和转移)的影响。
Cancer Lett. 2002-12-10
Cancer Prev Res (Phila). 2010-8-17
Nan Fang Yi Ke Da Xue Xue Bao. 2020-8-30
J Natl Cancer Inst. 1993-11-3
Clin Sci (Lond). 1998-3
NPJ Breast Cancer. 2025-1-14
Front Endocrinol (Lausanne). 2024
Front Nutr. 2024-2-21
Front Nutr. 2023-11-24
Perspect Medicin Chem. 2008-1-18
Eur Arch Otorhinolaryngol. 2007-12
J Clin Invest. 2007-7
Nat Protoc. 2007
Pediatrics. 2007-3
Nutr Metab (Lond). 2007-2-21
Am J Physiol Endocrinol Metab. 2007-6